Retinoic Acid Receptor α (RARα) Mutations in Human Leukemia

References

• de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15,17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature 1990; 347: 558–561
   PubMed Web of Science ®Google Scholar
• Borrow J, Goddard A D, Sheer D, Solomon E. Molecular analysis of APL breakpoint cluster region on chromosome 17. Science 1990; 249: 1577–1580
   PubMed Web of Science ®Google Scholar
• Kakizuka A, Miller W H, Jr, Umesono K, Warrell R P, Jr, Frankel S R, Murty V VVS, Dmitrovsky E, Evans R M. Chromosomal translocation t(15,17) in human acute pro-myelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991; 66: 663–674
   PubMed Web of Science ®Google Scholar
• Alcalay M, Zangrilli D, Pandolfi P P, Longo L, Mencarelli A, Giacomucci A, Rocchi M, Biondi A, Rambaldi A, LoCoco F, Diverio D, Donti E, Grignani F, Pelicci P G. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor α locus. Proceedings of the National Academy of Sciences of the United States of America. 1991; 88: 1977–1981
   Google Scholar
• Chen Z, Brand N J, Chen A, Chen S J, Tong J H, Wang Z Y, Waxman S, Zelent A. Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-α locus due to a variant t(11,17) translocation associated with acute promyelocytic leukaemia. EMBO Journal 1993; 12: 1161–1167
   PubMed Web of Science ®Google Scholar
• Redner R L, Rush E A, Faas S, Rudert W A, Corey S J. The t(5,17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 1996; 87: 882–886
   PubMed Web of Science ®Google Scholar
• Wells R A, Catzavelos C, Kamel-Reid S. Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nature Genetics 1997; 17: 109–113
   PubMed Web of Science ®Google Scholar
• Arnould C, Philippe C, Bourdon V, Gregoire M J, Berger R, Jonveaux P. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia. Human Molecular Genetics 1999; 8: 1741–1749
   PubMed Web of Science ®Google Scholar
• Lawson N D, Berliner N. Neutrophil maturation and the role of retinoic acid. Experimental Hematology 1999; 27: 1355–1367
   PubMed Web of Science ®Google Scholar
• Huang M E, Ye Y C, Chen S R, Chai J R, Lu J X, Zhoa L, Gu L J, Wang Z Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–572
   PubMed Web of Science ®Google Scholar
• Chomienne C, Ballerini P, Balitrand N, Daniel M T, Fenaux P, Castaigne S, Degos L. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood 1990; 76: 1710–1717
   PubMed Web of Science ®Google Scholar
• Castaigne S, Chomienne C, Daniel M T, Ballerini P, Berger R, Fenaux P, Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76: 1704–1709
   PubMed Web of Science ®Google Scholar
• Licht J D, Chomienne C, Goy A., Chen A, Scott A A, Head D R, Michaux J L, Wu Y, DeBlasio A, Miller W H, Jr, Zelenetz A D, Willman C L, Chen Z, Chen S J, Zelent A, Macintyre E, Veil A, Cortes J, Kantarjian H, Waxman S. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11,17). Blood 1995; 85: 1083–1094
   PubMed Web of Science ®Google Scholar
• Johnson R L, Tabin C J. Molecular models for vertebrate limb development. Cell 1997; 90: 979–990
   PubMed Web of Science ®Google Scholar
• Kastner P, Grondona J M, Mark M, Gansmuller A, LeMeur M, Decimo D, Vonesch J L, Dolle P, Chambon P. Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 1994; 78: 987–1003
   PubMed Web of Science ®Google Scholar
• Chazaud C, Chambon P, Dolle P. Retinoic acid is required in the mouse embryo for left-right asymmetry determination and heart morphogenesis. Development 1999; 126: 2589–2596
   PubMed Web of Science ®Google Scholar
• Taneja R, Rochette-Egly C, Plassat J L, Penna L, Gaub M P, Chambon P. Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. EMBO Journal 1997; 16: 6452–6465
   PubMed Web of Science ®Google Scholar
• Giguere V, Ong E S, Segui P, Evans R M. Identification of a receptor for the morphogen retinoic acid. Nature 1987; 330: 624–629
   PubMed Web of Science ®Google Scholar
• Petkovich M, Brand N J, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444–450
   PubMed Web of Science ®Google Scholar
• Heyman R A, Mangelsdorf D J, Dyck J A, Stein R B, Eichele G, Evans R M, Thaller C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992; 68: 397–406
   PubMed Web of Science ®Google Scholar
• Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen J Y, Staub A, Garnier J M, Mader S, Chambon P. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 1992; 68: 377–395
   PubMed Web of Science ®Google Scholar
• Benbrook D, Lernhardt E, Pfahl M. A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 1988; 333: 669–672
   PubMed Web of Science ®Google Scholar
• Brand N, Pctkovich M, Krust A, Chambon P, de The H, Marchio A, Tiollais P, Dejean A. Identitication of a second human retinoic acid receptor. Nature 1988; 332: 850–853
   PubMed Web of Science ®Google Scholar
• Krust A, Kastner P, Petkovich M, Zelent A, Chambon P. A third human retinoic acid receptor. hRAR-γ. Proceedings of the National Academy of Sciences of the United States of America. 1989; 86: 5310–5314
   Google Scholar
• Mangelsdorf D J, Borgmeyer U, Heyman R A, Zhou J Y, Ong E S, Oro A E, Kakizuka A, Evans R M. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes & Development 1992; 6: 329–344
   PubMed Web of Science ®Google Scholar
• de The H, Marchio A, Tiollais P, Dejean A. Differentiail expression and ligand regulation of the retinoic acid receptor alpha and beta genes. EMBO Journal 1989; 8: 429–433
   PubMed Web of Science ®Google Scholar
• Gallagher R E, Said F, Pua I, Papenhausen P R, Paietta E, Wiernik P H. Expression of retinoic acid receptor-alphamRNA in human leukemia cells with variable responsiveness to retinoic acid. Leukemia 1989; 3: 789–795
   PubMed Web of Science ®Google Scholar
• Brand N J, Petkovich M, Chambon P. Characterization of a functional promoter for the human retinoic acid receptor-alpha (hRAR-alpha). Nucleic Acid Research 1990; 18: 6799–6806
   PubMed Web of Science ®Google Scholar
• Pandolfi P P, Alcalay M, Fagioli M, Zangrilli D, Menearelli Diverio A. D., Biondi A, Lo Coco F, Rambaldi A, Grignani F, Rochette-Egly C, Gaube M P, Chambon P, Pelicci P G. Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia. EMBO Journal 1992; 11: 1397–1407
   PubMed Web of Science ®Google Scholar
• Zelent A. Translocation of the RARα locus to the PML or PLZF gene in acute promyelocytic leukaemia. British Journal of Haematology 1994; 86: 451–460
   PubMed Web of Science ®Google Scholar
• Hjalt T AH, Murray J C. Genomic structure of the human retinoic acid receptor-alphal gene. Mammalian Genome 1999; 10: 528–529
   PubMed Web of Science ®Google Scholar
• Leroy P, Nakshatri H, Chambon P. Mouse retinoic acid receptor alpha 2 isoform is transcribed from a promoter that contains a retinoic acid response element. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 10138–10142
   PubMed Web of Science ®Google Scholar
• Zelent A, Enver T, Gallagher R, Waxman S. RARα2 isoform in normal granulopoiesis and leukemia. Blood 1996; 88(Supplement I)52a, abstract
   Google Scholar
• Zelent A, Zhu J, Lanotte M, Gallagher R, Waxman S, Heyworth C M, Enver T. Differential expression of retinoic receptors during multilieage differentiation of haemopoitic progenitor cells-role of the RARα2 isoform in normal granulopoiesis and leukaemia. Blood 1997; 90(Supplement 1)44a–45a, abstract
   Google Scholar
• Nagpal S, Friant S, Nakshatri H, Chambon P. RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo. EMBO Journal 1993; 12: 2349–2360
   PubMed Web of Science ®Google Scholar
• de The H, Vivanco-Ruiz M M, Tiollais P, Stunnenberg H, Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 1990; 343: 177–180
   PubMed Web of Science ®Google Scholar
• Umesono K, Murakami K K, Thompson C C, Evans R M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 1991; 65: 1255–1266
   PubMed Web of Science ®Google Scholar
• Naar A M, Boutin J M, Lipkin S M, Yu V C, Holloway J M, Glass C K, Rosenfeld M G. The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell 1991; 65: 1267–1279
   PubMed Web of Science ®Google Scholar
• Nagpal S, Saunders M, Kastner P, Durand B, Nakshatri H, Chambon P. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 1992; 70: 1007–1019
   PubMed Web of Science ®Google Scholar
• Moras D, Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Current Opinion in Cell Biology 1998; 10: 384–391
   PubMed Web of Science ®Google Scholar
• Xu L, Glass C K, Rosenfeld M G. Coactivator and corepressor complexes in nuclear receptor function. Current Opinion in Genetics & Development 1999; 9: 140–147
   PubMed Web of Science ®Google Scholar
• Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997; 389: 349–352
   PubMed Web of Science ®Google Scholar
• Davie J R. Covalent modifications of histones : expression from chromatin templates. Current Opinion in Genetics & Development 1998; 173–178
   PubMed Web of Science ®Google Scholar
• McLnick A, Licht J U. Deconstructing a disease RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93: 3167–3715
   PubMed Web of Science ®Google Scholar
• Hiorns L R, Min T, Swansbury G J, Zelent A, Dyer M J, Catowsky D. Interstitial insertion of retinoic acid receptor-:alpha gene in acute promyelocytic leukemia with normal chromosomes 15 and 17. Blood 1994; 83: 2946–2951
   PubMed Web of Science ®Google Scholar
• Grimwade D, Gorman P, Duprez E, Howe K, Langabeer S, Oliver F, Walker H, Culligan D, Waters J, Pomfret M, Goldstone A, Burnett A, Freemont P, Sheer D, Solomon E. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. Blood 1997; 90: 4876–4885
   PubMed Web of Science ®Google Scholar
• Chillon M C, Gonzalez M, Garcia-Sanz R, Balanzategui A, Gonzalez D, Lopez-Perez R, Mateos M V, Alaejos J, Rayon C, Arbeteta J, Hernandez J M, Orfao A, San Miguel J. Two new 3′, PML breakpoints in t(15:17)(q22,q21)-positive acute promyelocytic leukemia. Genes Chromosones and Cancer 2000; 27: 35–43
   PubMed Web of Science ®Google Scholar
• Fenaux P, Chomienne C. Biology and treatment of acute promyelocytic leukemia. Current Opinion in Oncology 1996; 8: 3–12
   PubMedGoogle Scholar
• Alcalay M, Zangrilli D, Fagioli M, Pandolfi P P, Mencarelli A, LoCoco F, Biondi A, Pelicci P G. Expression pattern of the RARα/PMI, fusion gene in acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 1992; 89: 4840–4844
   PubMed Web of Science ®Google Scholar
• Li Y P, Andersen J, Zelent A, Rao S, Paietta E, Tallman M S, Wiernik P H, Gallagher R E. RARα1/RARα2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study. Blood 1997; 90: 306–312
   PubMed Web of Science ®Google Scholar
• Castaigne S, Balitrand N, de The H, DeJean A, Degos L, Chomienne C. A PML/retinoic acid receptor α fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood 1992; 79: 3110–3115
   PubMed Web of Science ®Google Scholar
• Lo Coeo F, Diverio D, Falini B, Biondi A, Nervi C, Pelicci P G. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. Blood 1999; 94: 12–22
   PubMed Web of Science ®Google Scholar
• Guidez F, Huang W, Tong J H, Dubois C, Balitrand N, Wax-Man S, Michaux J L, Martiat P, Degos L, Chen Z, Chomienne C. Poor response to all-trans retinoic acid therapy in a t(11 :17) PLZF/RARα patient. Leukemia 1994; 8: 312–317
   PubMed Web of Science ®Google Scholar
• Mozziconacci M J, Liberatore C, Grignani F, Sainty D, Pel-Icci P G, Birg F, Lafage-Pochitaloff M. Atypical response to all-trans retinoic acid in a der(5)t(5:17) acute promyelo-cytic leukemia. Leukemia 1999; 13: 862–868
   PubMed Web of Science ®Google Scholar
• Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M., Pelicci P G, Atwater S, Bishop J M. A PMLRARα transgene initiates murine acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 2551–2556
   PubMed Web of Science ®Google Scholar
• He L Z, Tribioli C, Rivi R, Peruzzi D, Pelicci P G, Soares V, Cattoretti G, Pandolfi P P. Acute leukemia with promyelocytic features in PML/RARα transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 5302–5307
   PubMed Web of Science ®Google Scholar
• He L Z, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi P P. Distint interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nature Genetics 1998; 18: 126–135
   PubMed Web of Science ®Google Scholar
• Cheng G X, Zhu X H, Men X Q, Wang L, Huang Q H, Jin X L, Xiong S M, Zhu J, Guo W M, Chen J Q, Xu S F, So E, Chan L C, Waxman S, Zelent A, Chen G Q, Dong S, Liu J X, Chen S J. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARα and NPM-RARα. Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 6318–6323
   PubMed Web of Science ®Google Scholar
• He L Z, Merghoub T, Pandolfi P P. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications. Oncogene 1999; 18: 5278–5292
   PubMed Web of Science ®Google Scholar
• Pollock J L, Westervelt P, Kurichety A K, Pelicci P G, Grisolano J L, Ley T J. A bcr-3 isoform of RARα-PML potentiates the development of PML-RARα-driven acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 15103–15108
   PubMed Web of Science ®Google Scholar
• Corral J, Lavenir I, Impey H, Warren A J, Forster A, Larson T A, Bell S, McKenzie A N, King G, Rabbitts T H. An MLL-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 1996; 85: 853–861
   PubMed Web of Science ®Google Scholar
• Castilla L H, Wijmenga C, Wang Q, Stacy T, Speck N A, Eckhaus M, Marin-Padilla M, Collins F S, Wynshaw-Boris A, Liu P P. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFβ-MYH11. Cell 1996; 87: 687–696
   PubMed Web of Science ®Google Scholar
• Gu H, Zou Y R, Rajewsky K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 1993; 73: 1155–1164
   PubMed Web of Science ®Google Scholar
• Smith A J, De Sousa M A, Kwabi-Addo B, Heppell-Parton A, Impey H, Rabbitts T H. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Nature Genetics 1995; 9: 376–385
   PubMed Web of Science ®Google Scholar
• Shockett P, Difilippantonio M, Hellman N, Schatr D G. A modified tetracycline-regulated system provides autoregu-latory, inducible gene expression in cultured cells and transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 6522–6526
   PubMed Web of Science ®Google Scholar
• Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, Horner J W, 2nd, Cordon-Cardo C, Yancopoulos G D, DePinho R A. Essential role for oncogenic Ras in tumour maintenance. Nature 1999; 400: 468–472
   PubMed Web of Science ®Google Scholar
• Grignani F, Ferrucci P F, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pelicci P G. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 1993; 74: 423–431
   PubMed Web of Science ®Google Scholar
• Chen Z, Guidez F, Rousselot P, Agadir A, Chen S J, Wang Z Y, Degos L, Zelent A, Waxman S, Chomienne C. PLZF-RARα fusion proteins generated from the variant t(11:17)(q23,q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 1178–1182
   PubMed Web of Science ®Google Scholar
• Jansen J H, Mahfoudi A, Rambaud S, Lavau C, Wahli W, Dejean A. Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxi-some-proliferator signaling pathways. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 7401–7405
   PubMed Web of Science ®Google Scholar
• Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P. PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. EMBO Journal 1993; 12: 3171–3182
   PubMed Web of Science ®Google Scholar
• Licht J D, Shaknovich R, English M A, Melnick A, Li J Y, Reddy J C, Dong S, Chen S J, Zelent A, Waxman S. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-α chimera generated in t(11:17)-asaociated acute promyelocytic leukemia. Oncogene 1996; 12: 323–336
   PubMed Web of Science ®Google Scholar
• Dong S, Zhu J, Reid A, Strutt P, Guidez F, Zhong H J, Wang Z Y, Licht J, Waxman S, Chomienne C, Chen Z, Zelent A, Chen S J. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-a fusion protein. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 3624–3629
   PubMed Web of Science ®Google Scholar
• Kogan S C, Hong S H, Shultz D B, Privalsky M L, Bishop J M. Leukemia initiated by PMLRARα: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable. Blood 2000; 95: 1541–1550
   PubMed Web of Science ®Google Scholar
• Daniel M T, Koken M, Romagne O, Barbey S, Bazarbachi A, Stadler M, Guillemin M C, Degos L, Chomienne C, de The H. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 1993; 82: 1858–1867
   PubMed Web of Science ®Google Scholar
• Dyck J A, Maul G G, Miller W H, Jr, Chen J D, Kakiruka A, Evans R M. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 1994; 76: 333–343
   PubMed Web of Science ®Google Scholar
• Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 1994; 76: 345–356
   PubMed Web of Science ®Google Scholar
• Kohen M H, Puvion-Dutilleul F, Guillemin M C, Viron A, Linares-Cruz G, Stuurmnn N, de Jong L, Szostecki C, Calvo F, Chomienne C, Degos L, Puvion E, de The H. The t(15:17) translocatioii alters a nuclear body in a retinoic acid-reversible fashion. EMBO Journal 1994; 13: 1073–1083
   PubMed Web of Science ®Google Scholar
• Koken M HM, Reid A, Quignon F, Chelbi-Alix M K, Davies J M, Kabarouski J HS, Zhu J, Dong S, Chen S J, Chen Z, Tan C C, Licht J, Waxman S, de Thé H., Zelent A. Leukemia-associated retinoic acid receptor α fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 10255–10260
   PubMed Web of Science ®Google Scholar
• Ruthardt M, Orleth A, Tomassoni L, Puccetti E, Riganelli D, Alcalay M, Mannucci R, Nicoletti I, Grignani F, Fagioli M, Pelicci P G. The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies. Oncogene 1998; 16: 1945–1953
   PubMed Web of Science ®Google Scholar
• Koken M H, Daniel M T, Gianni M, Zelent A, Licht J, Buzyn A, Minnrd P, Degos L, Varet B, de The H. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARα fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11:17)(q23,q21) APL patient. Oncogene 1999; 18: 1113–1118
   PubMed Web of Science ®Google Scholar
• Hummel J L, Wells R A, Dube I D, Licht J D, Kamel-Reid S. De-regulation of NPM and PLZF in a variant t(5,17) case of acute promyelocytic leukemia. Oncogene 1909; 18: 633–641
   Web of Science ®Google Scholar
• Grignani F, Testa U, Rogaia D, Ferrucci P E, Samoggia P, Pinto A, Aldinucci D, Gelmetti V, Fagioli M, Alcalay M, Seeler J, Grignani F, Nicoletti I, Peschle C, Pelicci P G. Effects on differentiation by the promyelocytic leukemia PML/RARα protein depend on the fusion on the PML protein dimerization and RARα DNA binding domains. EMBO Journal 1996; 15: 4969–4958
   Google Scholar
• Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R, Naoe T. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Research 1996; 56: 2945–2948
   PubMed Web of Science ®Google Scholar
• Raelson J V, Nervi C, Rosenauer A, Benedetti L, Monezak Y, Pearson M, Pelicci P G, Miller W H, Jr. The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 1996; 88: 2826–2832
   PubMed Web of Science ®Google Scholar
• Nervi C, Ferrara F F, Fanelli M, Rippo M R, Tomassini B, Ferrucci P F, Ruthardt M, Gelmetti V, Gambacorti-Passerini C, Diverio D, Grignani F, Pelicci P G, Testi R. Caspases mediate retinoic acid-induced degradation of the acute myelocytic leukemia PML/RARα fusion protein. Blood 1998; 92: 2244–2251
   PubMed Web of Science ®Google Scholar
• Fanelli M, Minucci S, Gelmetti V, Nervi C, Gambacorti-Passerini C, Pelicci P G. Constitutive degradation of PML/RARα through the proteasome pathway mediates retinoic acid resistance. Blood 1999; 93: 1477–1481
   PubMed Web of Science ®Google Scholar
• Zhu J, Gianni M, Kopf E, Honore N, Chelbi-Alix M, Koken M, Quignon F, Rochette-Egly C, de The H. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor α (RARα) and oncogenic RARα fusion proteins. Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 14807–14812
   PubMed Web of Science ®Google Scholar
• Naoe T, Kitamura K. Relationship between degradation of PML-RARα and differentiation. Fanelli M. Pelicci P G. Response. Blood 1999; 94: 1478–1479
   PubMed Web of Science ®Google Scholar
• Nervi C, Poindexter E C, Grignani F, Pandolfi P P, Lo Coco F, Avvisati G, Pelicci P G, Jetten A M. Characterisation of the PML-RARα chimeric product of the acute promyelocytic leukemia-specific t(15:17) translocation. Cancer-Research 1992; 52: 3687–3692
   PubMed Web of Science ®Google Scholar
• Ruthardt M, Testa U, Nervi C, Ferrucci P F, Grignani F, Puccetti E, Gripnani F, Peschle C, Pelicci P G. Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor a (RARα) and PLZF-RARα fusion proteins on retinoic acid signalling. Molecular and Cellular Biology 1997; 17: 4859–4869
   PubMed Web of Science ®Google Scholar
• Casini T, Pelicci P G. A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest. Oncogene 1999; 18: 3235–3243
   PubMed Web of Science ®Google Scholar
• Grignani F, Gelmetti V, Fanelli M, Rogaia D, De Matteis S, Ferrara F F, Bonci D, Gripnani F, Nervi C, Pelicci P G. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response. Oncogene 1999; 18: 6313–6321
   PubMed Web of Science ®Google Scholar
• Zhong S, Deva L, Rachez C, Cenciarelli C, Gandini D, Zhang H, Kalantry S, Freedman L P, Pandolfi P P. A RA-dependent, tumor growth suppressive transcription complex is the target of the PML-RARa and T18 oncoproteins. Nature Genetics 1999; 23: 287–295
   PubMed Web of Science ®Google Scholar
• Sitterlin D, Tiollais P, Transy C. The RAR alpha-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain. Oncogene 1997; 14: 1067–1074
   PubMed Web of Science ®Google Scholar
• Yeyati P L, Shaknovich R, Boterashvili S, Li J, Ball H J, Waxman S, Nason-Burchenal K, Dmitrovsky E, Zelent A, Lieht J D. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 1999; 18: 925–934
   PubMed Web of Science ®Google Scholar
• So C W, Dong S, So C K, Cheng G X, Huang Q H, Chen S J, Chan L. C. The impact of differential binding of wild-type RARα, PML-, PLZF- and NPM-RARα fusion proteins towards transcriptional co-activator, RIP-140, on retinoic acid responses in acute promyelocytic leukemia. Leukemia 2000; 14: 77–83
   PubMed Web of Science ®Google Scholar
• Hong S H, David G, Wong C W, Dejean A, Privalsky M L. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor α (RARα) acid PLZF-RARα oncoproteins associated with acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of American 1997; 94: 9028–9033
   PubMed Web of Science ®Google Scholar
• Lin R J, Nagy L, Inoue S, Shao W, Miller W H, Jr, Evans R M. Role of the histone deacetylase complex in acute promyelocytic leukemia. Nature 1998; 391: 811–814
   PubMed Web of Science ®Google Scholar
• Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara F F, Zamir I, Seiser C, Grignani F, Lazar M A, Minucci S, Pelicci P G. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia. Nature 1998; 391: 815–818
   PubMed Web of Science ®Google Scholar
• Guidez F, Ivins S, Zhu J, Söderström M, Waxman S, Zelent A. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARα underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 1998; 91: 2634–2642
   PubMed Web of Science ®Google Scholar
• Delva L, Cornic M, Balitrand N, Guidez F, Miclea J M, Delmer A, Teillet F, Fenaux P, Castaigne S, Degoa L, Chomienne C. Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 1993; 82: 2175–2181
   PubMed Web of Science ®Google Scholar
• Cornic M, Chomienne C. Induction of retinoid resistance by all-trans retinoic acid in acute promyelocytic leukemia after remission. Leukemia & Lymphoma 1995; 18: 249–257
   PubMed Web of Science ®Google Scholar
• Duprez E, Ruchaud S, Houge G, Martin-Thouvenin V, Valensi F, Kastner P, Berger R, Lanotte M. A retinoid acid “resistant” t(15,17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features. Leukemia 1992; 6: 1281–1287
   PubMed Web of Science ®Google Scholar
• Kizaki M, Matsushita H, Takayama N, Muto A, Ueno H, Awaya N, Kawai Y, Asou H, Kamada N, Ikeda Y. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-I) with retinoic acid-resistant features. Blood 1996; 88: 1824–1833
   PubMed Web of Science ®Google Scholar
• Shao W, Benedetti L, Lamph W W, Nervi C, Miller W H, Jr. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RARα mutation. Blood 1997; 89: 4282–4289
   PubMed Web of Science ®Google Scholar
• Imaizumi M, Suzuki H, Yoshinari M, Sato Saito A. T., Sugawara A, Tsuchiya S, Hatae Y, Fujimoto T, Kakizuka A, Konno T, Iinuma K. Mutations in the E-domain of RARα portion of the PML/RARα chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia. Blood 1998; 92: 374–382
   PubMed Web of Science ®Google Scholar
• Ding W, Li Y P, Nobile L M, Grills G, Carrera I, Paietta E, Tallman M S, Wiernik P H, Gallagher R E. Leukemia cellular retinoic acid resistance and missense mutations in the PML-RARα fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. Blood 1998; 92: 1172–1183
   PubMed Web of Science ®Google Scholar
• Robertson K A, Emami B, Collins S J. Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 1992; 80: 1885–1889
   PubMed Web of Science ®Google Scholar
• Tsai S, Collins S J. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocytic stage. Proceedings of the National Academy of Sciences of the United States of America 1993; 90: 7153–7157
   PubMed Web of Science ®Google Scholar
• Parrado A, West R, Jordan D, Bastard C, McKenna S, Whittaker J, Bentley P, White D, Chomienne C, Padua R A. Alterations of the retinoic acid receptor α (RARα) gene in myeloid and lymphoid leukaemias. British Journal of Haematology 1999; 104: 738–741
   PubMed Web of Science ®Google Scholar
• Morosetti R, Grignani F, Liberatore C, Pelicci P G, Schiller G J, Kizaki M, Bartram C R, Miller C W, Koeffler H P. Infrequent alterations of the RARα gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines. Blood 1996; 87: 4399–4403
   PubMed Web of Science ®Google Scholar
• Imamura J, Miyoshi I, Koeffler H P. p53 in hematologic malignancies. Blood 1994; 84: 2412–2421
   PubMed Web of Science ®Google Scholar
• Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd P J, Moss P AH, Taylor A MR. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 1999; 353: 26–29
   PubMed Web of Science ®Google Scholar
• Bullrich F, Rasio D, Kitada S, Starostik P, Kipps T, Keating M, Albitar M, Reed J C, Croce C M. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Research 1999; 59: 24–27
   PubMed Web of Science ®Google Scholar
• Grønbák K, Thor Straten P, Ralfkiaer E, Ahrenkiel V, Andersen M K, Hansen N E, Zeuthen J, Hou-Jensen K, Guldberg P. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood 1998; 92: 3018–3024
   PubMed Web of Science ®Google Scholar
• Naderi S, Blomhoff H K. Retinoic acid prevents phosphorylation of pRB in normal human lymphocytes: regulation of cyclin E, cyclin A, and p21Cip1. Blood 1999; 94: 1348–1358
   PubMed Web of Science ®Google Scholar
• Kipps T J. Signal transduction pathways and mechanisms of apoptosis in CLL-B lymphocytes: their role in CLL pathogenesis. Hematology & Cell Therapy 1997; 39: S17–S27
   PubMedGoogle Scholar
• Du C, Redner R L, Cooke M P, Lavau C. Overexpression of wild-type retinoic acid receptor α (RARα) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARα-fusion genes. Blood 1999; 94: 793–802
   PubMed Web of Science ®Google Scholar